The Centre for Neuroscience, Recovery & Mental Health KEY STRATEGIC PRIORITIES

Transcription

1 The Centre for Neuroscience, Recovery & Mental Health KEY STRATEGIC PRIORITIES

2 Diamantina Health Partners Diamantina Health Partners (DHP) was launched in July 2011, bringing together eight Queensland institutions with a shared vision and mission to deliver better health outcomes by integrating innovation and excellence in health research, clinical education, and patient care. Vision To be a premier international academic health sciences enterprise. Mission To achieve better health globally through the integration of clinical care, research and education. We will strengthen our partnerships, drive innovation and achieve excellence to improve health outcomes. Values Clinical and academic excellence Strong collaboration and integration Innovation and implementation Inclusive and open Respect, integrity, trust and accountability 2 Partners Themes Princess Alexandra Hospital Mater Health Services The University of Queensland Queensland University of Technology Translational Research Institute Metro South Addiction and Mental Health Services UQ Health Care Inala Indigenous Health Service Centre for Neuroscience, Recovery & Mental Health Chronic Diseased & Ageing Diamantina Comprehensive Cancer Centre Evidence & Innovation into Clinical Practice Integrated Trauma & Recovery Immunity, Inflammation & Infection Mothers, Babies & Early Development The Centre for Neuroscience, Recovery & Mental Health

3 The Centre for Neuroscience, Recovery & Mental Health Our Centre In collaboration with the Diamantina Health Partners, the Centre for Neuroscience, Recovery & Mental Health (the Centre) has been established. The Centre will facilitate the utilisation of research and education to effectively inform and improve healthcare for people with mental health problems. Our Vision Provision of world class neuroscience research that translates to better clinical outcomes and education programs for mental health. Our Mission Implement a multidisciplinary framework that encourages and supports collaboration between our partners to maximise the rehabilitation and recovery for individuals, carers and the community that are impacted by mental health problems. We will pursue four strategic priorities to help us achieve our vision Facititate Cross Discipline Collaboration Prioritise our Research Efforts Maximise Translation to Implementation Establish a Mental Health Learning Hub Key Strategic Priorities

4 1 Priority Area Facilitate Cross Discipline Collaboration The development of a partnership approach to establish and maintain collaborative research networks is a fundamental aspect of this Centre. By linking and engaging with our committee members and broader research community we will demonstrate the sharing, dissemination and translation of new knowledge. Goal Build and sustain key partnerships for a shared benefit. Strategies 1. Ensure that Centre Partners receive regular communication and updates about projects/ research/ opportunities of mutual interest and benefit. 2. Identify and map the networks and relationships with other key partners/ researchers to define how mutually beneficial relationships will be maintained and strengthened. 3. Identify the informal networks where information and networking foster freely. 4. Ensure all Centre Partners have a vested commitment to share and disseminate information. 5. Encourage new shared research projects that synergize partnerships in the centre. 6. Prioritize a small set of achievable projects so that members see the benefits of collaboration. 4 The Centre for Neuroscience, Recovery & Mental Health

5 2 Priority Area Prioritise our Research Efforts The Centre will facilitate the utilisation of research to effectively inform and improve healthcare for people with mental health problems. Prioritising research efforts by collectively identifying key research areas within the three core specialities of neuroscience, recovery paradigms and mental health research will facilitate improved healthcare. Goal Improve the research literacy of our community. Strategies 1. Deliver specialised training to improve skills in research methodology. 2. Provide mentorship opportunities for individuals completing Post Graduate work to improve the integration between research and clinical practice. Goal Identify key research areas within the speciality of neuroscience, recovery paradigms and mental health research. Strategies 1. Map all existing research from our Centre Partners. 2. Identify any gaps for new research proposals. 3. Investigate priority areas for consumers and carers. 4. Map complementary strengths within the Centre Partnership. 5. Identify joint grant opportunties/applications under DHP. 6. Identify opportunties to share infrastructure and other resources. 7. Establish skills in clinical trials with key partners around the following key focus areas: Interventions related to the treatment of mental illness using innovations in neurosurgery. Development and evaluation of pharmacological, psychological and other treatments for mental illness. Interventions related to the reduction of co-morbid physical disorders in those with mental health disorders. Interventions related to optimizing outcomes in those with Early Psychosis. Interventions related to the particular needs of Indigenous Communities & Multicultural Communities. 8. Link clinical trials skills with other themes within DHP in order to optimize efficiency and cross fertilisation. Key Strategic Priorities

6 3 Priority Area Maximise translation to implementation The Centre will ensure that new knowledge is translated into changed clinical and non-clinical practices. Goal Build translational skills to ensure good knowledge is utilised in practice, will be sustainable and embedded into the clinical delivery of care. Strategies 1. Enable and facilitate carer / consumer participation throughout phases of research to maximise outcomes for the community. 2. Provide the opportunity for dissemination, uptake and professional development of new skills and knowledge. 3. Recognise that changing a clinical process is timely- set realistic timeframes to enable long term sustainable change in clinical practices. 4. Ensure that there is regular evaluation of new skills and knowledge to enhance clinical outcomes, long term prognosis and recovery from mental health disorders. 5. Identify any existing research that can be undertaken as a collaborative translational project under DHP that will have a positive impact on individuals with mental illness in the clinical setting and in the broader community. 6. Provide the opportunity for peer reviewed publications based on improved mental health outcomes. 6 The Centre for Neuroscience, Recovery & Mental Health

7 4 Priority Area Establish the Mental Health Learning Hub The Centre will ensure excellence through the application and development of newly learnt clinical skills to ensure better outcomes for individuals with Mental Health problems. Goal Build a Centre of Excellence, that promotes a culture of learning, development and translation of new skills Strategies 1. In collaboration with Royal Australian and New Zealand College of Psychiatrists (RANZCP), review and sustain the Post Graduate Training in Psychiatry to ensure that Queensland Psychiatrists are trained in best practice care that is based on current practices and approaches. 2. Link clinicians through to formal education with our Centre Partners, based on their identified needs and professional development. 3. Provision of workshops/seminars to clinical staff based on day to day practical clinical application of new knowledge and skills for better translation and dissemination in the clinical setting. 4. Build the capacity of the non-clinical workforce to assist individuals that experience poor mental health. i.e; Mental Health First Aid Training. Key Strategic Priorities

8 The Centre for Neuroscience, Recovery and Mental Health Steering Committee Members Chair Professor David Crompton MBBS (Qld) Grad Dip Soc Sci (Psych) (UNE) FRANZCP FAChAM (RACP) Executive Director, Addiction and Mental Health Services Professor David Crompton is the Executive Director of Addiction and Mental Health Services in Metro South Health and Hospital Services. David worked in private practice as a rural general practitioner prior to commencing psychiatry training and spent 12 years in private psychiatry practice. David is a Professor of Psychiatry at University of Queensland. Professor Crompton has held leadership roles in Queensland Health and New South Wales Health - Mental Health Services. He was awarded OAM for development of community based Mental Health Services for Veterans, development of community Post Traumatic Stress Disorder, and Anxiety and Substance Abuse treatment services. David, is currently undertaking a PhD focussing on impact of disasters on psychological and physical health in Queensland. Professor John McGrath Richard Neilson Chief Executive Officer Queensland Alliance Richard Nelson is the Chief Executive Officer of Queensland Alliance for Mental Health Inc, the peak body for the community mental health sector. He has an extensive career in executive leadership and management in the not for profit and public sector. Richard is committed to strengthening the community mental health sector and is passionate about working towards a mental health system that is focused on people s recovery in their own homes and communities. Richard previously held the position of Deputy CEO of the Aboriginal Health Council of South Australia and has executive management experience in Aboriginal and Torres Strait Islander health policy, planning, national reform and education. He has also been a board member of the Health Consumers Alliance of South Australia and has a proven track record of achievement in community sector planning, policy development, organisational development and workforce planning with State and Federal Governments and Aboriginal community organisations. AM MBBS MD PhD FRANZCP Director of the Queensland Centre for Mental Health Research Professor John McGrath received his medical degree from the University of Queensland. John is currently the Director of the Queensland Centre for Mental Health Research. He holds appointments at the University Of Queensland Department Of Psychiatry, the Queensland Brain Institute and Griffith University. His research aims to generate and evaluate non genetic risk factors for schizophrenia. He has forged productive cross-disciplinary collaborations linking risk factor epidemiology with developmental neurobiology (e.g. using animal models to explore candidate exposures). In addition, he has supervised major systematic reviews of the incidence, prevalence and mortality of schizophrenia. He has won several national and international awards including the Premier's Award for Medical Research, a Queensland-Smithsonian Fellowship, a Rockefeller Foundation Bellagio Residency, and the Organ on Senior Research Award. The Australian government awarded John a Centenary Medal in 2003 and in 2007 he was appointed a Member of the Order of Australia (AM). In 2013, John was awarded the prestigious National Health and Medical Research Council (NHMRC) John Cade Fellowship, this will provide $750,000 a year for five years to study ways to prevent serious mental health disorders such as schizophrenia. 8 Professor Jenny Martin MBChB MA (Oxon) FRACP PhD GAICD Head, Princess Alexandra Hospital Southside Clinical School The University of Queensland Professor Jennifer Martin is a general physician and clinical pharmacologist employed jointly via the PAH and UQ as the Head of Clinical School. She has been involved in teaching, training and curriculum development for 20 years and is currently the teaching and learning representative in clinical pharmacology for the Royal College of Physicians. Previously Jenny worked in similar clinical/academic roles at the Alfred and St Vincent's Hospitals (Melbourne), where she undertook her PhD in the role of the macrophage in type 2 diabetes and post-doctoral research at the Walter and Eliza Hall Institute. Professor Martin has also studied health economics at Oxford University and has used this experience to serve on the Pharmaceutical Benefits Advisory Committee, the Economic Subcommittee of the PBAC and other Government committees examining appropriate allocation and use of pharmaceuticals. She has also led the QH Statewide Medicines Collaborative and the Translational Research Institute (TRI) Caucus. Her current research and education interests include pharmacogenetics and pharmacokinetics to improve drug choice and dose especially in vulnerable groups - she leads this a multi disciplinary medicines research group in the TRI. The Centre for Neuroscience, Recovery & Mental Health

9 Professor Elizabeth Kendall BA PhD PGD Psych Director of Research, Centre of National Research on Disability and Rehabilitation Griffith Health Institute Deputy Head of School (Research) School of Human Services and Social Work Griffith University Professor Elizabeth Kendall completed her PhD in 1997 on the topic of adjustment and coping following traumatic injury, for which she won the Dean s Commendation for Outstanding PhD Thesis (UQ). She has continued to build a research agenda in rehabilitation and innovation service systems for people who are managing the complex consequences of serious injuries, disabilities or chronic conditions. Elizabeth runs a collaborative research program with significant partners including Queensland Health, Motor Accident Insurance Commission and several large nonprofit organisations. She manages a research team of 40 researchers and has attracted over $14 million in research grants and consultancies, including 7 large Australian Research Council grants. She has over 150 publications in high quality journals such as Social Science and Medicine, American Journal of Public Health, Rehabilitation Psychology, Disability and Rehabilitation and has produced over 65 industry reports. She was Chair of the ARC College of Experts, Social Behavioural and Economic Sciences Panel Professor Ross Young BSc MSc Dip Clin Psych PhD Executive Dean, Faculty of Health Queensland University of Technology Professor Ross Young was appointed Executive Dean, Faculty of Health in He was previously Executive Director, Institute of Health and Biomedical Innovation (IHBI), QUT, from He is also a Visiting Research Fellow at the Alcohol Research Centre, University of California, Los Angeles and a Senior Clinical Psychologist at the Alcohol and Drug Assessment Unit, Princess Alexandra Hospital. His previous roles include Director of the Behaviour Research and Therapy Centre (Psychiatry) at The University of Queensland where he also undertook his PhD studies at The University of Queensland in the School of Psychology. Professor Young completed undergraduate psychology and postgraduate clinical psychology studies at The University of Otago, New Zealand. His research interests lie in the integration of psychological and biological risk factors in mental illness. His research includes work in substance misuse, schizophrenia, anxiety disorders and more broadly in behavioural medicine. This includes work in pharmacogenomics and the development of personalised medicine via the use of diagnostic gene chips. Professor Young is widely published and has over 190 published papers in genetic, medical, psychiatric and psychological journals. Professor Steve Kisely MD MSc PhD Grad Dip Ed Dip Mgt FRANZCP FRCPsych FFPH (UK) FAFPHM FRSPH FAChAM (RACP) School of Medicine The University of Queensland Professor Steve Kisely is a psychiatric epidemiologist at the University of Queensland. He is also Director of the Queensland Centre for Health Data Services (Health LinQ) and psychiatrist at Ipswich and Princess Alexandria Hospitals. Steve s research and clinical interests are in epidemiology/ pharmaco-epidemiology, chronic disease surveillance, health services research (HSR), and physical & psychiatric co-morbidity. Professor Kisely is the author of 143 full-length peerreviewed papers on physical/psychiatric co-morbidity, psychiatric epidemiology and health services research. He was the winner of Special Judges Award in the category of Best Use of IT in Clinical Care in Great Britain as part of the 1998 National Health Care IT Effectiveness Awards, and the Canadian Psychiatric Association s R.O. Jones Award in Professor Bryan Mowry MB BS BA(Hons) MD FRANZCP Director of Genetics, Queensland Centre for Mental Health Research Conjoint Professor of Psychiatry, Queensland Brain Institute The University of Queensland Affiliate Professor of Psychiatry, School of Medicine, Southern Clinical School The University of Queensland Professor Bryan is a psychiatrist who holds a MD degree (University of Queensland) in the molecular genetics of schizophrenia. Since 1990, he has conducted studies, with national and international collaborators, to identify susceptibility genes for this disorder. He is the recipient of grants from the Australian NHMRC (continuous since 1990) and the US NIMH. The primary goal of his psychiatric genomics program is to identify and functionally characterise susceptibility genes for schizophrenia (and related disorders) in order to (i) develop personalised treatments and novel therapeutics and (ii) to understand molecular and cellular mechanisms underlying disease. The program aims to achieve this goal by analyzing detailed clinical, neurocognitive and neuroimaging data together with genetic information in the form of genomewide association studies (GWAS), DNA sequencing, and sequence-based genomics. His lab has recently derived neuronal cells using induced pluripotent stem cell (ipsc) technology from schizophrenia patients and healthy controls and plans to use these stem cells for disease modeling and drug discovery. Key Strategic Priorities

10 Diamantina Health Partners January 2014 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part of this publication may be reproduced by any process without prior written permission from Diamantina Health Partners. Enquiries should be directed to Level 7 Translational Research Institute 37 Kent Street, Woolloongabba QLD 4102, Australia